Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses - a randomized, placebo-controlled clinical trial.
Eveleens Maarse BC, Ronner MN, Jansen MAA, Niemeyer-van der Kolk T, In 't Veld AE, Klaassen ES, Ahmad S, Itano A, McHale D, Moerland M. Eveleens Maarse BC, et al. Among authors: itano a. Immunol Res. 2024 Aug;72(4):776-787. doi: 10.1007/s12026-024-09484-7. Epub 2024 May 15. Immunol Res. 2024. PMID: 38748319 Free PMC article. Clinical Trial.
Impact of oral administration of single strain Lactococcus lactis spp. cremoris on immune responses to keyhole limpet hemocyanin immunization and gut microbiota: A randomized placebo-controlled trial in healthy volunteers.
Saghari M, Gal P, Grievink HW, Klaassen ES, Itano A, McHale D, Moerland M. Saghari M, et al. Among authors: itano a. Front Immunol. 2022 Dec 7;13:1009304. doi: 10.3389/fimmu.2022.1009304. eCollection 2022. Front Immunol. 2022. PMID: 36582231 Free PMC article. Clinical Trial.
Regulation of Peripheral Inflammation by a Non-Viable, Non-Colonizing Strain of Commensal Bacteria.
Ramani K, Cormack T, Cartwright ANR, Alami A, Parameswaran P, Abdou M, Wang I, Hilliard-Barth K, Argueta S, Raghunathan D, Caffry W, Davitt CJH, Romano FB, Ng A, Kravitz V, Rommel T, Sizova M, Kiran EU, Pradeep P, Ponichtera HE, Ganguly T, Bodmer M, Itano A. Ramani K, et al. Among authors: itano a. Front Immunol. 2022 Feb 2;13:768076. doi: 10.3389/fimmu.2022.768076. eCollection 2022. Front Immunol. 2022. PMID: 35185874 Free PMC article.
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3.
Murray JK, Qian YX, Liu B, Elliott R, Aral J, Park C, Zhang X, Stenkilsson M, Salyers K, Rose M, Li H, Yu S, Andrews KL, Colombero A, Werner J, Gaida K, Sickmier EA, Miu P, Itano A, McGivern J, Gegg CV, Sullivan JK, Miranda LP. Murray JK, et al. Among authors: itano a. J Med Chem. 2015 Sep 10;58(17):6784-802. doi: 10.1021/acs.jmedchem.5b00495. Epub 2015 Aug 31. J Med Chem. 2015. PMID: 26288216
50 results